The relevance of pharmacology in clinical oncology practice. The moderator thinks that

Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.

Oncogene·2020

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

Blood cancer journal·2017

A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset.

Psychological medicine·2016

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.

Oncogene·2013

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.

British journal of cancer·2013

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.

Clinical pharmacology and therapeutics·2013

Efficacy of Cryotherapy in Preventing Taxane-Induced Neuropathy: The CryoPac Randomised Controlled Trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: five-year results from the phase III KEYNOTE-564 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Thymic radiation is associated with worse outcomes in patients with NSCLC.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Systemic anticancer therapy for refractory malignant bowel obstruction in advanced cancer patients: a retrospective cohort study.

BMJ supportive & palliative care·2026

Neoadjuvant niraparib monotherapy for unresectable, homologous recombination deficiency-positive, high-grade serous ovarian cancer (NANT): a multicentre, single-arm, phase 2 trial.

The Lancet. Oncology·2026

Palliative Stoma Creation in Patients With Peritoneal Carcinomatosis and Mechanical Intestinal Obstruction: A Single-Center Experience.

The American surgeon·2026

Cannabidiol/cannabigerol exposure and neuropathy-related outcomes after neurotoxic chemotherapy: a real-world cohort study.

Frontiers in pain research (Lausanne, Switzerland)·2026

Clinical characteristics and immunotherapy in Chinese patients with Merkel cell carcinoma: a retrospective analysis.

Frontiers in oncology·2026

Randomised controlled trial of fluoxetine versus naltrexone in compulsive sexual behaviour disorder.

BMJ mental health·2026

Related Experiment Videos

The relevance of pharmacology in clinical oncology practice. The moderator thinks that

Related Concept Videos

Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset.

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.

Efficacy of Cryotherapy in Preventing Taxane-Induced Neuropathy: The CryoPac Randomised Controlled Trial.

Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study.

Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.

Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study.

Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: five-year results from the phase III KEYNOTE-564 study.

Thymic radiation is associated with worse outcomes in patients with NSCLC.

Systemic anticancer therapy for refractory malignant bowel obstruction in advanced cancer patients: a retrospective cohort study.

Neoadjuvant niraparib monotherapy for unresectable, homologous recombination deficiency-positive, high-grade serous ovarian cancer (NANT): a multicentre, single-arm, phase 2 trial.

Palliative Stoma Creation in Patients With Peritoneal Carcinomatosis and Mechanical Intestinal Obstruction: A Single-Center Experience.

Cannabidiol/cannabigerol exposure and neuropathy-related outcomes after neurotoxic chemotherapy: a real-world cohort study.

Clinical characteristics and immunotherapy in Chinese patients with Merkel cell carcinoma: a retrospective analysis.

Randomised controlled trial of fluoxetine versus naltrexone in compulsive sexual behaviour disorder.

Related Experiment Videos

The relevance of pharmacology in clinical oncology practice. The moderator thinks that

Related Concept Videos

Related Articles